These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23007681)

  • 21. Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.
    Chen C; Ortega F; Alameda L; Ferrer S; Simonsson US
    Eur J Pharm Sci; 2016 Oct; 93():319-33. PubMed ID: 27473307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers.
    McIlleron H; Norman J; Kanyok TP; Fourie PB; Horton J; Smith PJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1398-401. PubMed ID: 17951604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
    Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
    Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
    Ashokraj Y; Singh I; Kaur KJ; Kohli G; Bhade SR; Varma MV; Kaul CL; Panchagnula R
    Int J Tuberc Lung Dis; 2005 Jul; 9(7):791-6. PubMed ID: 16013776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?
    Noda A; Hsu KY; Noda H; Yamamoto Y; Kurozumi T
    J UOEH; 1983 Jun; 5(2):183-90. PubMed ID: 6679629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemotherapy of tuberculous meningitis in children and adults.
    Donald PR
    Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin.
    Ma R; Zhang J; Chen Z; Ma H; Liu X; Liang S; Wu P; Ge Z
    Neurol Res; 2022 Mar; 44(3):268-274. PubMed ID: 34581255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen.
    Seth V; Seth SD; Beotra A; Semwal OP; D'monty V; Mukhopadhya S
    Indian Pediatr; 1994 Mar; 31(3):279-85. PubMed ID: 7896362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.
    Maze MJ; Paynter J; Chiu W; Hu R; Nisbet M; Lewis C
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):955-60. PubMed ID: 27287650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients.
    Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K
    In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosis.
    Le Doare K; Barber N; Doerholt K; Sharland M
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23355589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interaction between rifampicin, isoniazid and cotrimoxazole in rabbits.
    Malhi R; Uppal R; Sharma PL
    Hum Exp Toxicol; 1992 Mar; 11(2):105-7. PubMed ID: 1349215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
    Weiner M; Burman W; Vernon A; Benator D; Peloquin CA; Khan A; Weis S; King B; Shah N; Hodge T;
    Am J Respir Crit Care Med; 2003 May; 167(10):1341-7. PubMed ID: 12531776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the effect of Nigella sativa (Black seeds) in isoniazid (INH)-induced hepatotoxicity in rabbits.
    Hassan AS; Ahmed JH; Al-Haroon SS
    Indian J Pharmacol; 2012; 44(6):678-82. PubMed ID: 23248393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifapentine for the treatment of tuberculosis: is it all it can be?
    Gordin FM
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1176-7. PubMed ID: 15161608
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
    Zwolska Z; Augustynowicz-Kopeć E; Niemirowska-Mikulska H
    Acta Pol Pharm; 2002; 59(6):448-52. PubMed ID: 12669769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampicin serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1106-11. PubMed ID: 19723399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.